Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Chang

Showing results (221-230 of 386) with videos related to

Pageof 39
Sort By:
Science Advances|March 12, 2025
Spatial 3D genome organization reveals intratumor heterogeneity in primary glioblastoma samplesQixuan Wang, Juan Wang, Radhika Mathur, et al.
Neuro-Oncology|October 15, 2021
Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imagingJulia Cluceru, Yannet Interian, Joanna J Phillips, et al.
Neuro-Oncology|December 17, 2013
Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trialOrin Bloch, Courtney A Crane, Yelena Fuks, et al.
Cancer|August 1, 2017
Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomasMichael Wahl, Susan M Chang, Joanna J Phillips, et al.
Neurosurgical Focus|May 20, 2006
Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studiesSandeep Kunwar, Susan M Chang, Michael D Prados, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2007
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study GroupSandeep Kunwar, Michael D Prados, Susan M Chang, et al.
JAMA Oncology|April 9, 2026
Prospective Genomic Profiling of Consecutive MeningiomasMinh P Nguyen, Kanish Mirchia, Brooke C Braman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium studyMonica E Loghin, Michael D Prados, Patrick Wen, et al.
Current Problems in Surgery|September 9, 2004
Brain metastasesMark E Shaffrey, Melike Mut, Anthony L Asher, et al.
Neuro-Oncology|February 11, 2004
Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium studyMichael D Prados, W K Alfred Yung, Howard A Fine, et al.
Pageof 39

Showing results (221-230 of 386) with videos related to

Sort By:
Pageof 39
Science Advances|March 12, 2025
Spatial 3D genome organization reveals intratumor heterogeneity in primary glioblastoma samplesQixuan Wang, Juan Wang, Radhika Mathur, et al.
Neuro-Oncology|October 15, 2021
Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imagingJulia Cluceru, Yannet Interian, Joanna J Phillips, et al.
Neuro-Oncology|December 17, 2013
Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trialOrin Bloch, Courtney A Crane, Yelena Fuks, et al.
Cancer|August 1, 2017
Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomasMichael Wahl, Susan M Chang, Joanna J Phillips, et al.
Neurosurgical Focus|May 20, 2006
Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studiesSandeep Kunwar, Susan M Chang, Michael D Prados, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2007
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study GroupSandeep Kunwar, Michael D Prados, Susan M Chang, et al.
JAMA Oncology|April 9, 2026
Prospective Genomic Profiling of Consecutive MeningiomasMinh P Nguyen, Kanish Mirchia, Brooke C Braman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium studyMonica E Loghin, Michael D Prados, Patrick Wen, et al.
Current Problems in Surgery|September 9, 2004
Brain metastasesMark E Shaffrey, Melike Mut, Anthony L Asher, et al.
Neuro-Oncology|February 11, 2004
Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium studyMichael D Prados, W K Alfred Yung, Howard A Fine, et al.
Pageof 39